NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five:
1) Federal Court Vacates FDA Rule on Laboratory-Developed Tests
2) Future of LDT Oversight Unclear Following Court's Rejection of FDA Rule
3) Beckman Coulter Targeting Low-Volume Labs With New Clinical Chemistry, Immunoassay Instrument
4) Under Constant Fear of Job Loss, FDA Reviewers Worry About Ensuring Diagnostic Efficacy, Safety
5) Siemens Healthineers Gains FDA 510(k) Clearance for Blood Clot Drug CDx